These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 32238157)
1. The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study. Lee JH; Han K; Huh JH Cardiovasc Diabetol; 2020 Apr; 19(1):44. PubMed ID: 32238157 [TBL] [Abstract][Full Text] [Related]
2. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study. Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936 [TBL] [Abstract][Full Text] [Related]
3. Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medication. Jung HH; Lee S Diabetes Obes Metab; 2020 Feb; 22(2):243-253. PubMed ID: 31602755 [TBL] [Abstract][Full Text] [Related]
4. Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study. Lee YB; Han K; Kim B; Lee SE; Jun JE; Ahn J; Kim G; Jin SM; Kim JH Cardiovasc Diabetol; 2019 Nov; 18(1):157. PubMed ID: 31733656 [TBL] [Abstract][Full Text] [Related]
5. Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study. Yun JS; Park YM; Han K; Cha SA; Ahn YB; Ko SH Cardiovasc Diabetol; 2019 Aug; 18(1):103. PubMed ID: 31412855 [TBL] [Abstract][Full Text] [Related]
6. Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study. Wang L; Zhang W; Dai J; Deng Q; Yan Y; Liu Q J Diabetes Investig; 2024 Aug; 15(8):1129-1139. PubMed ID: 38593274 [TBL] [Abstract][Full Text] [Related]
7. Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population. Kim MK; Han K; Park YM; Kwon HS; Kang G; Yoon KH; Lee SH Circulation; 2018 Dec; 138(23):2627-2637. PubMed ID: 30571256 [TBL] [Abstract][Full Text] [Related]
8. Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study. Kim MK; Han K; Koh ES; Kim ES; Lee MK; Nam GE; Kwon HS Cardiovasc Diabetol; 2019 Mar; 18(1):36. PubMed ID: 30890169 [TBL] [Abstract][Full Text] [Related]
9. Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial. Kumar A; Patel DR; Wolski KE; Lincoff AM; Kashyap SR; Ruotolo G; McErlean E; Weerakkody G; Riesmeyer JS; Nicholls SJ; Nissen SE; Menon V Diab Vasc Dis Res; 2019 Mar; 16(2):171-177. PubMed ID: 31014095 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the Effects of Fasting Glucose, Hemoglobin A Su WY; Chen SC; Huang YT; Huang JC; Wu PY; Hsu WH; Lee MY Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752391 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study. Kang YM; Cho YK; Lee SE; Park JY; Lee WJ; Kim YJ; Jung CH J Clin Endocrinol Metab; 2017 Sep; 102(9):3443-3451. PubMed ID: 28911137 [TBL] [Abstract][Full Text] [Related]
12. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications. Pareek M Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244 [TBL] [Abstract][Full Text] [Related]
13. Risk of Atrial Fibrillation in Relation to the Time Course of Type 2 Diabetes Mellitus and Fasting Blood Glucose. Yang S; Choi EK; Han KD; Kwon S; Lee SY; Park J; Choi YJ; Lee HJ; Moon I; Lee E; Lee SR; Cha MJ; Lim WH; Oh S Am J Cardiol; 2019 Dec; 124(12):1881-1888. PubMed ID: 31668346 [TBL] [Abstract][Full Text] [Related]
14. Fasting glucose level and all-cause or cause-specific mortality in Korean adults: a nationwide cohort study. Kim YS; Park YM; Han KD; Yun JS; Ahn YB; Ko SH Korean J Intern Med; 2021 May; 36(3):647-658. PubMed ID: 32623847 [TBL] [Abstract][Full Text] [Related]
15. Association of sleep disturbance with risk of cardiovascular disease and all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-HEALS. Choi Y; Choi JW Cardiovasc Diabetol; 2020 May; 19(1):61. PubMed ID: 32404104 [TBL] [Abstract][Full Text] [Related]
16. Impact of low fasting plasma glucose on mortality in the general population. Chevli PA; Ahmad MI; Hari K; Anees MA; Soliman EZ Diab Vasc Dis Res; 2020; 17(3):1479164120930599. PubMed ID: 32720509 [TBL] [Abstract][Full Text] [Related]
17. Association of fasting serum glucose level and type 2 diabetes with hepatocellular carcinoma in men with chronic hepatitis B infection: A large cohort study. Kim K; Choi S; Park SM Eur J Cancer; 2018 Oct; 102():103-113. PubMed ID: 30189372 [TBL] [Abstract][Full Text] [Related]
18. The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2. Davis TME; Chubb SAP; Davis WA Cardiovasc Diabetol; 2024 Oct; 23(1):362. PubMed ID: 39402659 [TBL] [Abstract][Full Text] [Related]
19. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans. Lee JW; Lim NK; Park HY BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706 [TBL] [Abstract][Full Text] [Related]
20. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]